April 8 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA THERAPEUTICS - DRAWING DOWN $50 MILLION ON ITS
EXISTING
CREDIT FACILITY
* ANIKA THERAPEUTICS - FOLLOWING DRAWDOWN, WILL HAVE TOTAL
LIQUIDITY OF APPROXIMATELY $140 MILLION, COMPRISED OF CASH AND
INVESTMENTS ON HAND
* ANIKA THERAPEUTICS INC - HAS NO DEBT MATURITIES THROUGH
END OF
2020, AND CREDIT FACILITY MATURES IN OCTOBER 2022
* ANIKA THERAPEUTICS INC - CO'S CREDIT FACILITY ALSO HAS A
$50
MILLION ACCORDION FEATURE THAT CO COULD POTENTIALLY ACCESS IN
FUTURE
* ANIKA THERAPEUTICS - EXPLORING OTHER SOURCES OF FUNDING
AIMED AT
SUPPORTING LIQUIDITY PROFILE, MAINTAINING BUSINESS,
ORGANIZATIONAL CONTINUITY THROUGH PANDEMIC
* ANIKA THERAPEUTICS - AT THIS TIME, CO DOES NOT ANTICIPATE
DISRUPTION TO SUPPLY OF PRODUCTS FOR PATIENTS DUE TO COVID-19
* ANIKA THERAPEUTICS - HAS ALSO TAKEN MEASURES TO MINIMIZE
DISRUPTION TO ONGOING CLINICAL TRIALS
Source text for Eikon: ID:nGNX6nnj1y
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;))